Synopsis of recent research by authors named "Chengde Wu"
- Chengde Wu's research primarily focuses on the treatment and molecular mechanisms involved in non-small cell lung cancer (NSCLC), including the evaluation of novel therapies and the impact of various factors on tumor progression and response to treatment.
- Key findings include the effectiveness of combining apatinib with radiotherapy in reducing CEA and VEGF expression, and the positive effects of Shenqi Fuzheng injection on leukopenia and T-cell subsets in patients undergoing radiotherapy for advanced NSCLC.
- Additionally, Wu has contributed to understanding the role of long non-coding RNA DLX6-AS1 in NSCLC tumorigenesis and the immunological implications of TP53 mutations in early-stage lung adenocarcinoma, as well as the development of new pharmacological agents targeting specific cancer pathways.